Abstract
Copy number loss of the PGR gene and decreased expression of progesterone receptor (PR) may account for worse clinical outcomes in some individuals with estrogen receptor α (ERα)-positive breast cancer. A recent report shows that PR activation inhibits estrogen-driven breast tumor growth by altering ERα chromatin binding and transcriptional activity.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 453-454 |
| Number of pages | 2 |
| Journal | Trends in Endocrinology and Metabolism |
| Volume | 26 |
| Issue number | 9 |
| DOIs | |
| State | Published - Sep 1 2015 |
ASJC Scopus subject areas
- Endocrinology, Diabetes and Metabolism
- Endocrinology
Divisions
- Medical Oncology
Fingerprint
Dive into the research topics of 'Progesterone receptor-estrogen receptor crosstalk: A novel insight'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS